Middle East Cancer Consortium

About MECC Cancer Registry Program Palliative Cancer Project Small Grant Project Other MECC Activities Useful Links

 

This site is hosted by the National Cancer Institute, National Institutes of Health in Bethesda, MD, USA.

Contact Information

Disclaimers




FUNDED PROJECTS

Principal Investigator(s) & Country of Origin

Title of Proposal

Institute(s)

A. Savva (Cyprus)

K. Arlitsch (USA)

Creation of an internet-based information infrastructure for cancer research in Cyprus

Nicosia General Hospital Cyprus

J. Cohen (Israel)

Application of MRI  for the localization of photodynamic therapy

Chaim Sheba Medical Center
Tel Hashomer, Israel

V. Neocleous (Cyprus)

Oncogene gene expression in UVR skin fibroblasts and Keratinocytes

Centre for Biomedical Sciences
Nicosia, Cyprus

C. Deltas (Cyprus)

Development of methodology for early and efficient presymptomatic detection of molecular tumor markers

Cyprus Institute of Neurology and Genetics Nicosia, Cyprus

S. Mordechai (Israel)

Diagnosis of tissue abnormalities using optical fiber based methods

Ben Gurion University
Beer-Sheva

J. Mahajna (Israel)

M. Ali-Shtayeh (Palestinian Authority)

Medicinal plants as a source of therapeutics for the treatment of hormone-refractory prostate cancer

R&D Regional Center
The Galilee Society, Israel

Al-Najah National University
Nablus, West Bank

E.  Friedman
(Israel)

K. Kyriacou (Cyprus)

Z. Abdeen
(Palestinian Authority)

A. Adamou (Cyprus)

Characterization of the mutational spectrum in BCRA genes in individuals of high risk for developing breast and ovarian cancer in the Mediterranean region

Tel Hashomer
Hospital

Nicosia Institute of Neurology & Genetics

Al-Quds University

 Nicosia General Hospital

Z. Kraim (Israel)

Metalloproteinase gene expression and activity in neoplastic and non-neoplastic human thyroid cells

Carmel Medical Center Haifa

Y. Assaraf (Israel)

An SSCP-based clinical assay for the identification of mutations in the reduced folate carrier gene

Department of Biology Technion, Haifa

I. Roisman (Israel)

R. Coleman (Israel)

J. Zidan (Israel)

Investigation of hereditary breast and ovarian cancer in Israel

Faculty of Medicine Technion, Haifa

Safed Hospital

S. Merchav (Israel)

Naturally-occurring STAT isoforms in normal and leukemic myeloid progenitors

Faculty of Medicine Technion, Haifa

C. Benayahu
(Israel)

Bone and tumors, from cell biology to diagnosis

Faculty of Medicine
Tel Aviv University

Y. Assaraf
(Israel)

Molecular cloning of a folate exporter gene associated with a novel resistance to antifolate anticancer drugs

Faculty of Biology
Technion, Haifa

E. Kahan
(Israel)

K. El-Najjar
(Palestinian Authority)

Primary care physicians’ knowledge and attitudes related to the prevention and control of cancer collaboration between Israel and Palestine

Rabin Medical Center
Petah Tikvah

MoH, Gaza

I. Vlodarsky
(Israel)

S. Ayesh
(Palestinian Authority)

Heparanase gene expression and involvement in tumor metastasis and angiogenesis

Hadassah Medical Center Jerusalem

Makassed Islamic Charitable Hospital, Jerusalem

S. Slavin (Israel)

H. Alian
(Palestinian Authority)

Innovative and cost-effective immunologic interventions for the treatment of blood cancer in children

Hadassah Medical Center Jerusalem

Bet Jalla Hospital
West Bank, Palestinian National Authority

Jacob Bar-tana (Israel)

Rachel Hertz (Israel)

Nabeel Hahas (Palestinian Authority)

Suppression of tumor development by (ω-3) polyunsaturated fatty acids Israel

 

Department of Human Nutrition,
Hadassah Medical School
Jerusalem

Al-Quds University
Abu-Dies

Ephrat Levy-Lahad (Israel)

Samir Al-Kayed (Jordan)

Elias Awad (Palestinian Authority)

Genetics of Breast Cancer in Arab Middle Eastern Populatinos

Medical Genetics Unit,
Shaare Zedek Hospital
Jerusalem

Department of Radiotherapy,
Al-Bashir Hospital
Amman, Jordan

Department of Oncology,
Beit Jala Hospital
Bethlehem

Rachel Bar-Shavit (Israel)

Beatrice Uziely (Israel)

Mahjer Sughayer (Palestinian Authority)

The Role of Protease Activated Receptor (PAR) Family in Tumor Invasion and Metastasis Israel

Department of Oncology,
Hadassah Hospital
Jerusalem

Department of Pathology,
Makkassed Hospital
Mount of Olives

Vasilios Tanos (Cyprus)

Froso Iacovou (Cyprus)

Demetrakis Christodoulides (Cyprus)

Constantinos Pattichis (Cyprus)

Gynecological Cancer Diagnostic Telepathology and Teleconsultation Network

Ban of Nicosia
Oncology Center

Department of Histopathology,
Nicosia General Hospital

Department of Obstetrics & Gynecology,
Paphos General Hospital

Department of Computer Sciences,
University of Cyprus Nicosia

Amr Soliman (Egypt)

Tareq Al-Jaberi (Jordan)

Khamis El-Najjar (Palestinian Authority)

A population-based study of colorectal cancer in Egypt, Jordan, and Palestine: Exploring the Early-Onset Disease

Faculty of Medicine
Menofeia

Department of Surgery, Jordan University
Amman, Jordan

Department of Hematology-Oncology,
Shifa Hospital, Gaza

Daniel Wreschner (Israel)

Pavlos Neophytou (Cyprus)

Changes in Gene Expression Elicited by Activation of the Breast Cancer Associated MUC1/Y Receptor Protein

Department of Cell Research & Immunology
Tel Aviv

University
Mendel Center for Biomedical Sciences Nicosia, Cyprus

Jamal Mahajna (Israel)

Hussam Massalha (Palestinian Authority)

Natural Products as Sensitizers of Chemoresistant Tumour Cells

Galilee R&D Society Eilaboun, Israel

Department of Life Sciences,
Al-Quds University
Abu Dies

Nathan Cherny (Israel)

Bassam Al-Hijawi (Jordan)

Mahmoud Iliam (Palestinian Authority)

Michael Boyiadzis (Cyprus)

Middle East Collaborative Cancer Pain Survey

Department of Medical Oncology,
Shaare Zedek Hospital
Jerusalem

Cancer Registry
Ministry of Health
Amman

Department of Oncology, Beit Jala Hospital Bethlehem

Cancer Registry,
Ministry of Health
Nicosia, Cyprus

Morris Srebnik (Israel)

Reuven Reich (Israel)

The Design and Evaluation of C1 Bridged Phosphono-boronates as Matrix Metalloproteinase-2 Inhibitors Israel

Department of Natural Products,
Hebrew University Jerusalem

Joav Horn (Israel)

Abdel Razzaq Salhab (Palestinian Authority)

Bassam Al-Hijawi (Jordan)

Breast Cancer Risk Factors among Different Ethnic Groups

Department of Oncology, Assaf Harofe
Hospital
Zerifin

Department of Oncology, Beit Jala Hospital Bethlehem

Cancer Registry,
Ministry of Health
Amman, Jordan

Esther Granot (Israel)

Arnon Nagler (Israel)

The effect of an ω-3 fatty acid enriched diet on chronic graft-versus-host disease of the liver Israel

Department of Pediatrics, Hadassah Hospital Jerusalem

Department of Bone Marrow Transplantation, Hadassah Hospital Jerusalem

Tamar Peretz (Israel)

Aviram Nissan (Israel)

Ram Spira (Israel)

Mahmoud Badriyah (Israel)

Screening for BRCA-1 and BRCA-2 mutations in Palestinian women with breast cancer

Department of Oncology, Hadassah Hospital
Ein Kerem, Jerusalem

Department of Surgery, Hadassah Hospital
Mount Scopus, Jerusalem

Reuven Reich (Israel)

Breast Cancer and Transcription Factor AP-2

Department of Pharmacology,
Hebrew University Jerusalem

Nadir Arber (Israel)

Hisham Darwish (Palestinian Authority)

Why is colorectal cancer rare among Palestinians and common among Israelis? A molecular and epidemiological approach.

Department of Gastroenterology,
Ichilov Hospital
Tel Aviv

Department of Biochemistry,
Faculty of Medicine,
El-Quds University
Abu Dies

Gadi Spira (Israel)

Nimer Assay (Israel)

Angiogenic factors may prevent post-operative liver failure following hepatic resection in experimental cirrhosis

Technion Medical School, Haifa, Israel

Upper Galilee Medical Services

Samy El-Badawy (Egypt)

Cancer research infrastructure development workshop

National Cancer Institute Cairo, Egypt

Daniel H. Wreschner (Israel)

Pavlos Neophytou (Cyprus)

Serum Levels of the Tumor Marker Muci Isoforms for Breast Cancer Diagnosis in Cypriot Families and in Non-Familial Patients

Faculty of Medicine Technion, Haifa

Mendel Center for Biomedical Services Lefkosia, Cyprus

Eitan Friedman (Israel)

Kyproula Christodoulou (Cyprus)

Adamos Adamou (Cyprus)

Ziad Abdeen (Palestinian Authority)

Identifying novel genomic regions and genes associated with inherited predisposition to breast and ovarian cancer Israel

 

 

Oncogenetics Unit,
Institute of Genetics
Chaim Sheba Medical Center

Department of Electron Microscopy and Molecular Pathology,
Cyprus Institute of Neurology & Genetics
Nicosia, Cyprus

Bank of Cyprus Oncology Centre
Nicosia, Cyprus

Al Quds University Jerusalem

Amr Soliman (Egypt)

Kamal Bani Hani (Jordan)

Khalil Hamdan and A.R. Salhab (Palestinian Authority)

Farhat Ben Ayed (Tunisia)

Melissa Bondy (USA)

Exploring Oxidative Damage in Premenopausal Breast Cancer Patients from Egypt, Jordan, Palestine, and Tunisia

National Cancer Institute Cairo, Egypt

Irbid
Gaza & West Bank

Salah Ben Aziz Cancer Center, Tunisia

M.D. Anderson Cancer Center
Houston, Texas

Pavlos I. Neophylou (Cyprus)

Samir Al-Kayed (Jordan)

Establishment of DNA and serum banks for Jordanian familial cancer patients and relatives

Mendel Center for Biomedical Sciences
Nicosia, Cyprus

Radiotherapy and Oncology Department,
Al Bashir Hospital
Amman, Jordan

Amr Soliman (Egypt)

Nidal Al-Masri (Jordan)

A pilot study to investigate the epidemiology of non-Hodgkin’s Lymphoma in Egypt and Jordan

National Cancer Institute, Cairo University

Jordan University for Science and Technology

Amy Avgar (Israel)

Carol El-Jabari (Palestinian Authority)

The impact of an empowerment model on Palestinian and Israeli Women coping with Breast Cancer: A Proposal for Action Research

 

JDC-Brookdale Institute
Jerusalem, Israel

Patient’s Friends Society
Jerusalem, Palestinian Authority

Eldad J. Dann (Israel)

Alyan Husein (Palestinian Authority)

Acute myeloid leukemia in-patients from different ethnic origin: Incidence, age, genetic factors, and environmental factors

 

Department of Hematology and Bone Marrow Transplantation,
Rambam Medical Center Haifa, Israel

Beit Jala Hospital
Bethlehem, Palestinian Authority

Eitan Friedman (Israel)

Kyriacos Kakoullis (Cyprus)

Mohammad A. Sultan (Jordan)

Characterisation of the mutational spectrum in BRCA genes in individuals at high risk for developing breast and ovarian cancer from Cyprus and Jordan

Oncogenetics Unit,
Sheba Medical Center
Tel-Hashomer, Israel

Mendel Center for Biomedical Sciences
Nicosia, Cyprus

Sultan Medical Labs
Amman, Jordan

Emma Guttman-Yassky (Israel)

Shai Linn (Israel)

Ronit Sarid (Israel)

Reuven Bergman (Israel)

Bassam Qasem (Jordan)

Investigation of Human Herpesvirus-89 (HHV-8) Transmission routes among Kaposi’s sarcoma patients and their families

Department of Dermatology,
Rambam Medical Center

Bruce Rappaport Faculty of Medicine
Haifa, Israel

Department of Epidemiology,
Rambam Medical Center

Faculty of Life Sciences,
Bar Ilan University
Ramat Gan, Israel

Jordan Cancer Registry
MoH, Amman, Jordan

Taleb H. Al-Tel (Palestinian Authority)

Musa H. Abu Zarga (Jordan)

Jamal Mahajna (Israel)

The synthesis of novel, potent, and selective modulators of tyrosine kinases for cancer therapeutics

Studies and Projects Unit,
An-Najah National University Nablus, Palestinian Authority

Chemistry Department,
Jordan University
Amman, Jordan

R&D Regional Center,
The Galilee Society, Israel